Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder-Reference-Cited by-同舟云学术

Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder

Published:2023-01-17 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Hussain Imran,Tandi Rishman,Singh Gurpreet,Kaur Gurnoor,. Abhishek,Dodda Saikrishna,Patel Dirgha,Natarajan Balaganesh,Maram Tejaswini,Kedia Ansh,Vempati Roopeessh,Sahu Sweta,Choubey Udit

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference17 articles.

1. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease;Stubbs J;Semin Dial,2007

2. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain;Yamashita T;Biochem Biophys Res Commun,2000

3. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease;Hasegawa H;Kidney Int,2010

4. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers;Larsson T;Kidney Int,2003

5. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men;Antoniucci DM;J Clin Endocrinol Metab,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Periodontitis on Fibroblast Growth Factor 23 Levels in Predialysis Chronic Kidney Disease Patients;Cureus;2024-07-23

2. Bone mineral density and related clinical and laboratory factors in peritoneal dialysis patients: Implications for bone health management;PLOS ONE;2024-05-16